Clinical Trials Browser

Completed × NIH × Arsenic Trioxide × Clear all

Burkitt Lymphoma, Leukemia, Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating

NCT00454480 2013-08-26

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Phase 2/3 Completed

2,000 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00036842 2013-06-24

Arsenic Trioxide in Treating Men With Germ Cell Cancer

Phase 2 Completed

Genitourinary

Testicular Germ Cell Tumor, Testicular Neoplasms

NCT00005618 2013-06-21

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia

Phase 2 Completed

Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00005999 2013-06-21

Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Phase 2 Completed

Gynecologic

Uterine Cervical Neoplasms

NCT00006008 2013-06-21

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003934 2013-06-05

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

Phase 3 Completed

420 enrolled

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00009867 2013-06-04

Arsenic Trioxide in Treating Patients With Urothelial Cancer

Phase 2 Completed

35 enrolled

Ureteral Neoplasms, Urethral Neoplasms

NCT00045565 2013-04-09

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Phase 1 Completed

30 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00124605 2013-01-07

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

Phase 1 Completed

24 enrolled

Plasma cell

Multiple Myeloma

Clinical Trials

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Arsenic Trioxide in Treating Men With Germ Cell Cancer

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia

Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

Arsenic Trioxide in Treating Patients With Urothelial Cancer

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma